Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

A well-known diabetes drug has gotten a lot more popular over the last two years. In June 2021, Wegovy, a new formulation of semaglutide, the active ingredient in the diabetes drug, Ozempic, was approved for weight loss, even in those who don’t have diabetes. While it’s only indicated for people with obesity, celebrities with seemingly healthy weights have claimed to be giving themselves the at-home injections in hopes of fitting into particularly form-fitting outfits for special events. If you so much as Google “Wegovy” even once, you’ll likely start seeing ads on social media for telehealth companies that help manage…

Read More

The primary cause of acne is clogged pores. Your pores can be clogged by bacteria, dead-skin cells or sebum, an oily substance secreted by your skin. The clogs cause redness and inflammation, which can be painful. Some doctors and patients believe that our diets can be the root cause of certain types of acne, but, for the most part, our lifestyles and hygiene are not to blame. Many women experience hormonal acne, which flares up at specific times during their menstrual cycles, or because of hormonal conditions, such as polycystic ovarian syndrome (PCOS), a disorder that affects many women. What…

Read More

There’s a shortage of the weight-loss drug Wegovy (semaglutide) and compounding pharmacies have been stepping in to manufacture their own versions and fill the gap. Unfortunately, not all compounding pharmacies are the same, and some specialists fear that patients are getting dangerous or inappropriate versions of the drug.  MedShadow reached out to Dan Lynch, PharmD, Director of Regulatory Services at Symphony Pharmacy, to discuss what compounding pharmacies are and if your healthcare provider prescribes a compounded a drug, how to make sure you’re working with a reputable pharmacy that will provide safe compounded medicines. MedShadow: To start off, what is…

Read More

Over the past decade, the Food and Drug Administration (FDA) has initiated or supported recalls on a handful of drugs, including metformin, ranitidine (Zantac), angiotensin II receptor blockers (ARB) (valsartan, losartan and irbesartan), varenicline (Chantix), rifampin (Rifadin) and rifapentine (Priftin) — which treat gastroesophageal reflux disease (GERD) and other conditions, such as heart disease and high blood pressure and aid in smoking cessation. These drugs that treat a variety of conditions have been found to contain the same chemical contaminant: N-nitrosodimethylamine (NDMA), which may cause cancer. MedShadow answers frequently asked questions about the chemical itself and the drugs that contain…

Read More

A Petition Was Filed For a Black Box Warning for SGLT-2 Inhibitors A petition was filed on June 24 that called for a black box warning for SGLT-2 inhibitors that are being prescribed for off-label used. The diabetes drug metformin is having a moment, as it may help stop COVID-19 deaths. And a cavalier and rebellious attitude in younger folks who think that they’re safe from COVID-19 may be the reason infection rates are surging in that demographic. The Dangers of a Common Diabetes Drug A citizen’s petition by Public Citizen was filed to the FDA on Wednesday, June 24,…

Read More